Dr David Werring, PhD, FRCP, ESO

David Werring is a Reader in Clinical Neurology and Honorary Consultant Neurologist at UCL Institute of Neurology, Queen Square, and the National Hospital for Neurology and Neurosurgery (NHNN), University College Hospitals (UCH) NHS Foundation Trust. Dr Werring is leading a research programme into stroke, with a particular interest in small vessel disease, especially intracerebral haemorrhage and cerebral amyloid angiopathy. He is Chief Investigator for two large UK-wide stidues: CROMIS-2 (Clinical Relevance of Microbleeds in Stroke) study (www.ucl.ac.uk/cromis-2) and the Genetic and Observational Study in Subarachnoid Haemorrhage (GOSH). Both of these studies include large, well-phenotyped cohorts for genetic analyses. He is also investigating new imaging biomarkers and treatments for cerebral amyloid angiopathy. He is Stroke specialty clinical lead for the NIHR North Thames Clinical Research Network. He is a member of the faculty of the European Stroke Organisation Conference and the scientific committee of the International Stroke Conference. He has an interest in the genetics of various types of intracranial bleeding including intracerebral haemorrgage (including those related to anticoagulants) and subarachnoid haemorrhage.